V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10268863 | 10073274 | null | 87.6 | null | 2020-04-06 | 2020-04-13 | Avelumab | 02 | null | CARBOPLATIN + GEMCITABINE | 100041984 |
| 10270563 | 10073275 | 1.84 | 100.8 | null | 2017-01-28 | 2017-02-12 | Avelumab | 02 | N | CAPECITABINE + OXALIPLATIN | 101157955 |
| 10274788 | 10073277 | 1.62 | 56 | null | 2019-02-08 | 2019-05-17 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101034551 |
| 10276207 | 10073279 | null | 73.5 | null | 2021-04-03 | 2021-05-08 | Avelumab | 02 | null | NIVOLUMAB | 100139082 |
| 10279408 | 10073280 | 1.73 | 84.8 | Curative (C) | 2016-07-15 | 2016-08-05 | Venetoclax | null | N | VENETOCLAX | 100876226 |
| 10281510 | 10073281 | 1.72 | 76.1 | null | 2019-04-05 | 2020-03-06 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 101234141 |
| 10287206 | 10073282 | 1.68 | 51.2 | null | 2019-07-01 | 2021-03-13 | DARATUMUMAB | 02 | null | DARATUMUMAB | 101219188 |
| 10292215 | 10073284 | 1.71 | 55 | null | 2020-12-27 | 2020-12-27 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100920188 |
| 10294663 | 10073285 | 1.7 | 100 | null | 2021-11-24 | 2021-11-30 | Avelumab | 02 | null | AVELUMAB | 101492984 |
| 10301537 | 10073288 | null | null | Neo-adjuvant (N) | 2016-04-09 | 2018-04-28 | null | 02 | N | BACILLUS CALMETTE-GUERIN | 101229632 |
| 10302678 | 10073289 | 1.68 | 80 | Palliative (P) | 2018-11-02 | 2018-11-27 | null | 02 | N | POMALIDOMIDE | 100580028 |
| 10304944 | 10073291 | 1.78 | 62.45 | 03 | 2018-09-07 | 2019-01-05 | null | 02 | N | RADIUM 223 | 101676107 |
| 10307220 | 10073293 | null | 78 | null | 2022-05-25 | 2022-05-28 | Radium 223 | 02 | null | POMALIDOMIDE | 100973123 |
| 10308624 | 10073295 | 1.79 | 71.8 | null | 2017-12-08 | 2017-12-21 | null | 99 | null | ATEZOLIZUMAB | 101030613 |
| 10311993 | 10073296 | null | null | null | 2020-04-28 | 2020-04-30 | BCG Intravesical | 02 | null | BACILLUS CALMETTE-GUERIN | 100885216 |
| 10313054 | 10073298 | 1.53 | 81.9 | Palliative (P) | null | 2018-08-04 | null | 02 | N | POMALIDOMIDE | 101463948 |
| 10314040 | 10073299 | 1.56 | 81.6 | null | 2019-05-15 | 2019-05-15 | null | 02 | null | POMALIDOMIDE | 101155920 |
| 10314302 | 10073300 | 1.8 | 61.8 | null | 2021-12-21 | 2021-12-27 | Bortezomib + Daratumumab | null | null | BORTEZOMIB + DARATUMUMAB | 101500828 |
| 10318813 | 10073301 | 1.71 | 79.1 | null | null | 2020-09-23 | Bortezomib + Daratumumab | 02 | null | BORTEZOMIB + DARATUMUMAB | 100441879 |
| 10318898 | 10073302 | 1.54 | 75.2 | null | null | 2019-10-01 | null | 02 | null | CARBOPLATIN + PACLITAXEL | 100795384 |
| 10324889 | 10073305 | 1.8 | 79.4 | Palliative (P) | 2022-03-03 | 2022-03-03 | null | 02 | N | POMALIDOMIDE | 101262419 |
| 10329035 | 10073306 | 1.64 | 61 | Curative (C) | 2020-02-05 | 2020-02-05 | BCG Intravesical | 02 | N | BACILLUS CALMETTE-GUERIN | 100904689 |
| 10330398 | 10073309 | 1.78 | 72 | null | 2022-02-09 | 2022-02-09 | BCG Intravesical | 02 | null | BACILLUS CALMETTE-GUERIN | 100291968 |
| 10330979 | 10073310 | 1.61 | 90.7 | 03 | 2020-07-27 | 2020-12-20 | null | 02 | N | CARBOPLATIN + PEMETREXED | 100452643 |
| 10333576 | 10073311 | 1.7 | 65.6 | null | null | 2018-12-28 | null | 02 | null | IXAZOMIB + LENALIDOMIDE | 101130252 |
| 10354581 | 10073313 | 1.56 | 86.9 | null | 2020-12-22 | 2021-06-18 | null | 2 | null | RITUXIMAB + VENETOCLAX | 100820369 |
| 10374886 | 10073318 | 1.65 | 84.8 | 03 | 2022-04-27 | 2022-04-27 | null | 02 | N | BORTEZOMIB + DARATUMUMAB | 101053096 |
| 10383158 | 10073320 | 1.85 | 47.2 | Curative (C) | 2019-08-06 | 2020-05-23 | FLUOROURACIL | 99 | null | DABRAFENIB | 100700369 |
| 10385774 | 10073322 | 1.8 | 68.8 | Palliative (P) | 2021-12-01 | 2021-12-01 | Bortezomib + Panobinostat | 02 | N | BORTEZOMIB + PANOBINOSTAT | 101162058 |
| 10387807 | 10073323 | 1.59 | 44.8 | 03 | null | 2019-05-20 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 100494608 |
| 10390166 | 10073324 | 1.68 | 88.8 | null | 2022-01-14 | 2022-01-14 | Melphalan IV High dose | 02 | null | MELPHALAN | 100576185 |
| 10393881 | 10073327 | 1.85 | 98.6 | Palliative (P) | 2019-03-02 | 2019-03-02 | Palbociclib | 02 | N | PALBOCICLIB | 101109475 |
| 10394092 | 10073328 | 1.64 | 73 | Palliative (P) | 2022-02-15 | 2022-05-13 | CABOZANTINIB | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101218214 |
| 10397323 | 10073330 | 1.88 | 70.4 | Palliative (P) | 2017-11-10 | 2017-11-17 | DABRAFENIB | 2 | N | CETUXIMAB | 101420043 |
| 10404614 | 10073332 | 1.75 | 96.4 | Palliative (P) | 2019-03-27 | 2019-09-26 | DABRAFENIB | 02 | N | CISPLATIN + GEMCITABINE | 101714696 |
| 10409542 | 10073333 | 1.68 | 82.2 | null | 2021-11-30 | 2021-12-04 | PVD | 02 | null | BORTEZOMIB + PANOBINOSTAT | 100586671 |
| 10415900 | 10073334 | 1.67 | 54.5 | Adjuvant (A) | 2019-05-10 | 2020-05-10 | Vinorelbine (oral) | null | N | DABRAFENIB | 101412971 |
| 10421926 | 10073336 | 1.72 | 90.7 | null | 2020-06-05 | 2020-06-14 | Bortezomib + Panobinostat | 02 | null | BORTEZOMIB + PANOBINOSTAT | 101205507 |
| 10422545 | 10073337 | 1.76 | 76.6 | null | 2018-01-25 | 2018-07-25 | Cisplatin + Vinorelbine (PO) | 02 | null | NIRAPARIB | 101696199 |
| 10425742 | 10073340 | 1.74 | 59 | null | 2021-08-12 | 2021-08-12 | Chlorambucil | 02 | null | CHLORAMBUCIL | 101324934 |
| 10425811 | 10073341 | 1.72 | 68.8 | null | null | 2022-05-19 | MELPHALAN | 02 | null | MELPHALAN | 100147381 |
| 10427505 | 10073343 | null | null | Disease modification (D) | null | 2021-08-23 | null | 02 | null | OXALIPLATIN + MDG | 100477650 |
| 10438324 | 10073345 | 1.72 | 100 | null | 2021-09-23 | 2021-09-23 | Ipilimumab | 02 | N | ERIBULIN | 101721919 |
| 10439306 | 10073346 | null | null | Palliative (P) | 2018-02-04 | 2018-09-17 | Cytarabine HD + Rituximab | 02 | N | ISATUXIMAB + POMALIDOMIDE | 101529428 |
| 10444165 | 10073347 | 1.68 | null | Palliative (P) | 2019-10-02 | 2019-10-02 | Doxorubicin + Olaratumab | 02 | N | BENDAMUSTINE + OBINUTUZUMAB | 100926689 |
| 10449361 | 10073348 | null | 70 | null | 2019-04-25 | 2020-07-25 | TALIMOGENE LAHERPAREPVEC | N | null | LIPOSOMAL DOXORUBICIN | 101620296 |
| 10457185 | 10073349 | 1.67 | 74.9 | null | 2019-01-04 | 2019-01-05 | Cytarabine Low Dose | 02 | null | SUNITINIB | 101304930 |
| 10465757 | 10073351 | null | null | null | 2022-01-11 | 2022-01-12 | CYTARABINE | 02 | null | OBINUTUZUMAB | 101283390 |
| 10468857 | 10073352 | 1.58 | 75.3 | 03 | 2020-03-28 | 2020-03-28 | Mitomycin Intravesical | 02 | N | GEMCITABINE + TREOSULPHAN | 101815249 |
| 10473777 | 10073355 | 1.62 | 53.8 | null | 2022-03-04 | 2022-03-24 | Liposomal Doxorubicin (Caelyx) | 02 | null | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101465874 |